Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk pati...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a770e270785e4086ae02f7c3e2b058e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a770e270785e4086ae02f7c3e2b058e9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a770e270785e4086ae02f7c3e2b058e92021-12-04T16:01:36ZAortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials10.15420/cfr.2018.41.22057-75592057-7540https://doaj.org/article/a770e270785e4086ae02f7c3e2b058e92019-05-01T00:00:00Zhttps://www.cfrjournal.com/articles/Aortic-Stenosis-Heart-Failure-Clinical-Trialshttps://doaj.org/toc/2057-7540https://doaj.org/toc/2057-7559Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk patients to patients with intermediate risk. Assessment of heart failure-related outcomes include the use of functional assessments, disease-specific quality of life surveys and standardised ascertainment of events, such as hospitalisations. Multiple statistical approaches are currently being tested to account for recurrent events such as hospitalisations for heart failure or to combine binary and continuous outcomes, both intended to assess the holistic burden of the disease, as opposed to the traditional analysis of time to first event.Ernest SpitzerRebecca T HahnPhilippe PibarotTon de VriesJeroen J BaxMartin B LeonNicolas M Van MieghemRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENCardiac Failure Review , Vol 5, Iss 2, Pp 99-105 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
Diseases of the circulatory (Cardiovascular) system RC666-701 Ernest Spitzer Rebecca T Hahn Philippe Pibarot Ton de Vries Jeroen J Bax Martin B Leon Nicolas M Van Mieghem Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
description |
Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk patients to patients with intermediate risk. Assessment of heart failure-related outcomes include the use of functional assessments, disease-specific quality of life surveys and standardised ascertainment of events, such as hospitalisations. Multiple statistical approaches are currently being tested to account for recurrent events such as hospitalisations for heart failure or to combine binary and continuous outcomes, both intended to assess the holistic burden of the disease, as opposed to the traditional analysis of time to first event. |
format |
article |
author |
Ernest Spitzer Rebecca T Hahn Philippe Pibarot Ton de Vries Jeroen J Bax Martin B Leon Nicolas M Van Mieghem |
author_facet |
Ernest Spitzer Rebecca T Hahn Philippe Pibarot Ton de Vries Jeroen J Bax Martin B Leon Nicolas M Van Mieghem |
author_sort |
Ernest Spitzer |
title |
Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
title_short |
Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
title_full |
Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
title_fullStr |
Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
title_full_unstemmed |
Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials |
title_sort |
aortic stenosis and heart failure: disease ascertainment and statistical considerations for clinical trials |
publisher |
Radcliffe Medical Media |
publishDate |
2019 |
url |
https://doaj.org/article/a770e270785e4086ae02f7c3e2b058e9 |
work_keys_str_mv |
AT ernestspitzer aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT rebeccathahn aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT philippepibarot aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT tondevries aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT jeroenjbax aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT martinbleon aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials AT nicolasmvanmieghem aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials |
_version_ |
1718372752913596416 |